Mr. Artem Arutyunyan Sr. Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 1095 Village Dr Unit 206, Orcutt, CA 93455 Phone: 820-946-9401 |
Dr. Michael I Callis, PH.D., MSCP Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 4610 Cherry Ave, Orcutt, CA 93455 Phone: 805-868-0471 |
Ms. Debra Meeks Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 1125 E. Clark Ave, Coast Valley Substance Abuse Treatment Center, Orcutt, CA 93455 Phone: 505-739-1512 |
Ms. Vanessa Irene Paul, LMFT Counselor Medicare: Not Enrolled in Medicare Practice Location: 535 E Clark Ave # A, Orcutt, CA 93455 Phone: 805-863-9067 |
Mr. Moises Caro, LMFT Counselor Medicare: Medicare Enrolled Practice Location: 195 S. Broadway, Suite 201, Orcutt, CA 93455 Phone: 805-757-1259 |
Brenee English Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 144 George Lane,, Orcutt, CA 93455 Phone: 805-781-3535 |
News Archive
Judicial Watch, the public interest group that investigates and prosecutes government corruption, announced today that it filed a lawsuit against the Obama Department of Health and Human Services to obtain documents related to President Obama's closed-door health care meetings with Vice President Biden, HHS Secretary Sebelius, Vice President Biden, Speaker Pelosi, Majority Leader Reid and union officials in violation of a campaign promise to broadcast all health care discussions on C-SPAN.
As concerns about bacterial resistance to antibiotics grow, researchers are racing to find new kinds of drugs to replace ones that are no longer effective. One promising new class of molecules called acyldepsipeptides - ADEPs - kills bacteria in a way that no marketed antibacterial drug does - by altering the pathway through which cells rid themselves of harmful proteins.
A pair of studies by researchers at the University of Massachusetts Medical School, the University of Trento in Italy, and the University of Geneva in Switzerland, point to a promising new anti-retroviral strategy for combating HIV-1.
Now in new research published on the preprint server bioRxix*, a novel formulation of the drug Niclosamide (NIC) is observed to be effective against SARS-CoV-2 and MERS-CoV in mouse models; it also protects against methicillin-resistance Staphylococcus aureus pneumonia and inflammatory lung damage.
Funeral director Kevin Spitzer has been overwhelmed with COVID-related deaths in the small city of Aberdeen, South Dakota.
› Verified 3 days ago